文献速递慢性肾脏病血液净化与透析肾移植

儿童CKD「保静脉」倡议:一项质量改进研究

"Save the Vein" Initiative in Children With CKD: A Quality Improvement Study.
PubMed 文献 · Am J Kidney Dis · 2021-01-07

该质量改进研究在单中心儿童医院纳入CKD 3-5期、透析或肾移植后住院患儿,通过教育、电子病历个体化备注、限制患肢腕带及血管通路团队参与等措施,提高优势臂PIV置管比例。基线优势臂置管为47%(34/72),干预后升至93%(345/371),<5岁患儿由25%(2/8)升至94%(58/62)。

要点

  • 多学科教育联合电子病历备注与限制腕带可提高优势臂PIV置管率。
  • 干预后优势臂PIV置管比例由47%升至93%,<5岁患儿由25%升至94%。
  • 仅10%的PIV置管位于肘前静脉,有助于保护未来动静脉内瘘血管。

核心结论

  • 关于静脉保护重要性的教育及标准化识别流程,可引导儿童CKD患者的PIV置管位置并可能保护其血管资源。

研究设计与样本

  • 质量改进研究,单中心儿童医院,纳入2018年9月至2020年8月住院的CKD 3-5期、接受透析和/或肾移植后患儿;基线数据为2017年1月1日至6月30日PIV置管位置的回顾性数据。

主要发现

  • 基线期72例次PIV置管中34例次(47%)位于优势臂,<5岁患儿8例次中仅2例次(25%)位于优势臂。
  • 干预后93名患儿共371例次PIV置管中345例次(93%)位于优势臂,<5岁患儿62例次中58例次(94%)位于优势臂。
  • 371例次PIV置管中仅38例次(10%)位于肘前静脉。

关键数值与推荐

  • 质量改进措施包括:对多学科团队、患者及家长进行静脉保护重要性教育;在电子病历中置入个体化备注标明首选置管手臂;使用「限制患肢」腕带;血管通路团队参与以减少置管尝试次数。

临床怎么用

  • 对住院儿童CKD患者,应通过多学科教育、电子病历备注、限制腕带及血管通路团队参与等标准化流程,优先在优势臂置入PIV导管以保护非优势臂血管。

局限性

  • 单中心研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: The preferred vascular access for hemodialysis recipients is an arteriovenous fistula in the nondominant arm. Prior placement of a peripheral intravenous (PIV) catheter can lead to vascular injury and limit options for arteriovenous fistula creation, a particular problem for children, who may need hemodialysis for their entire lifetime. We instituted an initiative to increase the frequency of PIV catheter placement in the dominant arm for hospitalized pediatric patients with advanced chronic kidney disease (CKD). STUDY DESIGN: Quality improvement initiative. SETTING & PARTICIPANTS: Children with CKD stage 3-5, receiving dialysis, and/or following kidney transplantation who were hospitalized at one children's hospital between September 2018 and August 2020. QUALITY IMPROVEMENT ACTIVITIES: Retrospective data on PIV catheter location for patients from January 1 to June 30, 2017, served as baseline data. Quality improvement activities consisted of: 1) education of the multidisciplinary treatment team, patients, and parents regarding importance of vein preservation; 2) placement of individualized notes in the electronic medical record identifying the preferred arm for PIV catheter placement; 3) use of "restricted extremity" arm bands; and 4) vascular access team participation to minimize attempts for PIV catheter placement. OUTCOME: Monthly compliance with placement of PIV catheters in dominant arms. ANALYTICAL APPROACH: Location of PIV catheter placements were determined monthly and used to create run charts describing compliance. RESULTS: At baseline and before institution of this initiative, 34 of 72 (47%) PIV catheters were placed in patients' dominant arms, with only 2 of 8 (25%) PIV catheters placed in the dominant arm for children aged<5 years. After instituting the initiative, 345 of 371 (93%) PIV catheters were placed in the dominant arm of 93 children; in children aged<5 years, 58 of 62 (94%) PIV catheters were placed in the dominant arm. Only 38 of 371 (10%) PIV catheters were placed in the antecubital vein. LIMITATIONS: Single-center study. CONCLUSIONS: Education regarding the importance of vein preservation, along with implementation of a standardized process for identifying children for whom vein preservation is important, can help direct PIV catheter placement and potentially preserve vasculature in pediatric patients with CKD.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Singh NS, Grimes J, Gregg GK, et al. "Save the Vein" Initiative in Children With CKD: A Quality Improvement Study. Am J Kidney Dis. 2021. PMID: 33421455. doi:10.1053/j.ajkd.2020.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。